Sunday 19 November |
|
DAY 1 | Room 3A | Room 3B | Hall 1B | Hall 1C | Room 11B - Workshop | Careers Zone, Main Exhibition Hall |
| ||
08:00 | Event Registration | Early Career Professional Welcome Early Career Professional Welcome 08:00 (45 mins) Lisa Stott, Sosei Heptares |
08:00 | ||||||
08:05 | 08:05 | ||||||||
08:10 | 08:10 | ||||||||
08:15 | 08:15 | ||||||||
08:20 | 08:20 | ||||||||
08:25 | 08:25 | ||||||||
08:30 | 08:30 | ||||||||
08:35 | 08:35 | ||||||||
08:40 | 08:40 | ||||||||
08:45 | ELRIG - Opening Session ELRIG - Annual Review - Visons & Values 08:45 (10 mins) Melanie Leveridge, GSK ELRIG - Equality, Diversity & Inclusion Guiding Principals 08:55 (5 mins) Clare Viney, Vitae ELRIG - Lifetime Achievement Award - A Career In Drug Discovery 09:00 (20 mins) Steve Rees, AstraZeneca Innovation and Automation during a Pandemic 09:20 (50 mins) Rob Howes, DHSC |
Platinum Sponsorship Presentation |
08:45 | ||||||
08:50 | 08:50 | ||||||||
08:55 | 08:55 | ||||||||
09:00 | 09:00 | ||||||||
09:05 | 09:05 | ||||||||
09:10 | 09:10 | ||||||||
09:15 | 09:15 | ||||||||
09:20 | 09:20 | ||||||||
09:25 | 09:25 | ||||||||
09:30 | 09:30 | ||||||||
09:35 | 09:35 | ||||||||
09:40 | 09:40 | ||||||||
09:45 | 09:45 | ||||||||
09:50 | 09:50 | ||||||||
09:55 | 09:55 | ||||||||
10:00 | 10:00 | ||||||||
10:05 | 10:05 | ||||||||
10:10 | Refreshment Break | 10:10 | |||||||
10:15 | 10:15 | ||||||||
10:20 | 10:20 | ||||||||
10:25 | 10:25 | ||||||||
10:30 | 10:30 | ||||||||
10:35 | 10:35 | ||||||||
10:40 | 10:40 | ||||||||
10:45 | 10:45 | ||||||||
10:50 | New Approaches in Infection Biology Chairs: David Pallin, CRL Adrian Goldman, U. Helsinki |
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd Chairs: Nikki Carter, Excalibur Healthcare Emily Adams, Liverpool School of Tropical Medicine and Mologic |
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA Chairs: Wesley Blackaby, Servier Oliver Rausch, Storm Therapeutics Ltd |
Alzheimer’s Research UK Chairs: John Isaac, Janssen Neuroscience David Reynolds, AstronauTx Ltd |
Workshop Gaining a career in industry: Learning tips and tricks from the inside 10:50 (60 mins) Allan Jordan, Sygnature Discovery |
10:50 | |||
10:55 | 10:55 | ||||||||
11:00 | New Approaches in Infection Biology Neuropilin-1 facilitates SARS-CoV2 cell entry and infectivity 11:00 (30 mins) Maria Anastasina, University of Helsinki Diverse neutralizing SARS-CoV-2 antibodies identified from large-scale synthetic phage libraries target rare epitopes and retain binding to variants of concern. 11:30 (30 mins) Tom Yuan — Twist Bioscience |
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd Q-POCTM, a paradigm shift in rapid multiplex molecular diagnostics 11:00 (30 mins) Jonathan OHalloran, QuantumDx Transforming Drug Discovery Through Precision Research 11:30 (30 mins) Stephen Hague — 10x Genomics |
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA Discovery of risdiplam (evrysdi) - A medicine for the treatment of spinal muscular atrophy 11:00 (30 mins) Hasane Ratni , F. Hoffmam-La Roche A Fully Automated Data Analysis Workflow for Gene Expression-Based Screening 11:30 (30 mins) Gabriela Nass Kovacs — Genedata AG |
Alzheimer’s Research UK Alzheimer’s Research UK and its support for translational research. 11:00 (30 mins) Sara Imarisio, ARUK Coding cells for health: building translational disease models for drug discovery and therapeutics 11:30 (30 mins) Sara Gomes — bit.bio Marta Rucka — bit.bio |
11:00 | ||||
11:05 | 11:05 | ||||||||
11:10 | 11:10 | ||||||||
11:15 | 11:15 | ||||||||
11:20 | 11:20 | ||||||||
11:25 | 11:25 | ||||||||
11:30 | 11:30 | ||||||||
11:35 | 11:35 | ||||||||
11:40 | 11:40 | ||||||||
11:45 | 11:45 | ||||||||
11:50 | 11:50 | ||||||||
11:55 | 11:55 | ||||||||
12:00 | New Approaches in Infection Biology Functional analysis of Bartonella pathogenicity factors might contribute to novel therapeutic concepts 12:00 (30 mins) Volkhard Kempf , Goethe University of Frankfurt am Main |
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd A luminescent reporter cell line for authentic SARS-CoV-2 infection and neutralising antibody activity 12:00 (30 mins) Nick Matheson, University of Cambridge |
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA mRNA Lightning platform for the discovery of selective small molecule mRNA regulatory drugs 12:00 (30 mins) Iris Alroy, Anima Biotech |
Alzheimer’s Research UK Identification of tool compounds targeting the SRSF1-dependent nuclear export of pathological C9ORF72-repeat transcripts 12:00 (30 mins) Lianne Van Beek, CRL Tennore Ramesh, Sheffield Institute for Translational Neuroscience (SITraN) |
12:00 | ||||
12:05 | 12:05 | ||||||||
12:10 | 12:10 | ||||||||
12:15 | 12:15 | ||||||||
12:20 | 12:20 | ||||||||
12:25 | 12:25 | ||||||||
12:30 | Refreshment Break | Workshop Chairs: Lilian Hunt, EDIS, Wellcome Trust Inclusive research and experimental design 12:30 (60 mins) Lilian Hunt, EDIS, Wellcome Trust |
12:30 | ||||||
12:35 | 12:35 | ||||||||
12:40 | 12:40 | ||||||||
12:45 | 12:45 | ||||||||
12:50 | 12:50 | ||||||||
12:55 | 12:55 | ||||||||
13:00 | 13:00 | ||||||||
13:05 | 13:05 | ||||||||
13:10 | 13:10 | ||||||||
13:15 | 13:15 | ||||||||
13:20 | 13:20 | ||||||||
13:25 | 13:25 | ||||||||
13:30 | 13:30 | ||||||||
13:35 | 13:35 | ||||||||
13:40 | 13:40 | ||||||||
13:45 | 13:45 | ||||||||
13:50 | 13:50 | ||||||||
13:55 | 13:55 | ||||||||
14:00 | New Approaches in Infection Biology Targeting the human RED-SMU1 splicing complex as a basis for host-directed anti-influenza therapy 14:00 (30 mins) Nadia Naffakh, Institut Pasteur, CNRS Introducing TRFID, a UK-leading BSL3 translation biology facility for Infectious Diseases at Alderley Park 14:30 (5 mins) Helen Bright — Medicines Discovery Catapult LabLogic Life Sciences range has something for everyone 14:35 (5 mins) Lucy Farmer — LabLogic Systems Limited FidaBio: Characterizing Biomolecular behaviour by measuring and monitoring changes in hydrodynamic radius 14:40 (5 mins) Jo Walter — Fida Biosystems ApS |
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd Diagnostics for epidemics, pandemics and neglected tropical disease 14:00 (30 mins) Emily Adams, Liverpool School of Tropical Medicine and Mologic Mesoporous silica & PLGA nanoparticles for next-generation drug delivery & targeted therapeutic technologies 14:30 (5 mins) Philippe Saint-Cricq-Riviere — nanoComposix Assist Plus 14:35 (5 mins) Sharon Barnard — INTEGRA Biosciences |
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA Dynamic RNAs and Structure-Guided Small Molecule Drug Discovery 14:00 (30 mins) Isaac Kimsey, Nymirum Yang Zheng, Nymirum DNA-Encoded Library Technology for Drug Discovery 14:30 (5 mins) Assunta Romano — Merck Life Science |
Alzheimer’s Research UK Small molecule inhibitors of carboxylesterase Notum to potentiate Wnt signalling 14:00 (30 mins) Nicky Willis, UCL DDI Quantifying Morphological Change Using Label-Free Live-Cell Analysis 14:30 (15 mins) Jasmine Trigg — Sartorius |
Workshop Chairs: Anita Ramanathan, Word Cortex Exceptional Science Presentations: How to Effectively Communicate the Value of Your Work 14:00 (45 mins) Anita Ramanathan, Word Cortex |
14:00 | |||
14:05 | 14:05 | ||||||||
14:10 | 14:10 | ||||||||
14:15 | 14:15 | ||||||||
14:20 | 14:20 | ||||||||
14:25 | 14:25 | ||||||||
14:30 | 14:30 | ||||||||
14:35 | Tecan UK Ltd |
14:35 | |||||||
14:40 | Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA Integrated Drug Discovery: Chemistry and Biology working together to create innovative solutions 14:40 (5 mins) Catherine Stace — Domainex |
14:40 | |||||||
14:45 | New Approaches in Infection Biology Studies of the membrane-bound pyrophosphatase as a potential drug target against protist parasites 14:45 (30 mins) Keni Vidilaseris, University of Helsinki |
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd EMERGING DIAGNOSTIC TECHNOLOGIES IN CLINICAL MICROBIOLOGY 14:45 (30 mins) Alex Van Belkum, Biomeirieux |
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA Small activating RNAs from concept to Phase 2 clinical trial 14:45 (30 mins) Vikash Reebye Nagy Habib , MiNA Therapeutics |
Alzheimer’s Research UK Development of eIF2B modulators for the treatment of neurodegenerative disease 14:45 (30 mins) Duncan Scott, Alborada Drug Discovery Institute, Cambridge |
14:45 | ||||
14:50 | 14:50 | ||||||||
14:55 | 14:55 | ||||||||
15:00 | 15:00 | ||||||||
15:05 | 15:05 | ||||||||
15:10 | 15:10 | ||||||||
15:15 | Refreshment Break | 15:15 | |||||||
15:20 | 15:20 | ||||||||
15:25 | 15:25 | ||||||||
15:30 | 15:30 | ||||||||
15:35 | 15:35 | ||||||||
15:40 | 15:40 | ||||||||
15:45 | New Approaches in Infection Biology Developing inhibitors that block adhesin-collagen interactions 15:45 (30 mins) Dirk Linke, University of Oslo PerkinElmer’s Tools to study virus-host interaction and virus inhibition 16:15 (15 mins) Louise Affleck — PerkinElmer |
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd Computer literate? Novel AI based reading of lateral flow devices 15:45 (30 mins) Daniel Wise, Excalibur Healthcare Design your molecular-based assays with confidence: Using ATCC’s Genome Portal bioinformatics platform to select wide-ranging, sequence-verified materials 16:15 (5 mins) Rebecca Charlton — LGC - ATCC Don't Let the Antibody be a Variable in Your Assay 16:20 (5 mins) Mark Twigden — Cell Signaling Technology Introducing Cytek cFluorTM Reagents and Assays 16:25 (5 mins) Michelle Jackson — Cytek Bio |
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA Drugging RNA Modifying Enzymes – METTL3 Inhibitors as a novel therapeutic strategy for Acute Myeloid Leukemia 15:45 (30 mins) David Hardick, Storm Therapeutics Konstantinos Tzelepis , The Milner Therapeutics Institute |
Alzheimer’s Research UK Gene editing to treat expanded CAG/CTG repeat disorders 15:45 (30 mins) Vincent Dion, Cardiff Dementia Research Institute The new generation of live cell shipments 16:15 (5 mins) Simon Myrbäck — Cellbox Solutions High-Throughput Genome Editing for Disease Models 16:20 (5 mins) Nick Clare — Synthego Ulysses - Arctoris' end-to-end automation platform for accelerated drug discovery 16:25 (5 mins) Daniel Thomas — Arctoris Ltd |
Workshop How to select the best nanoparticle for next-gen drug delivery 15:45 (60 mins) Philippe Saint-Cricq-Riviere — nanoComposix |
15:45 | |||
15:50 | 15:50 | ||||||||
15:55 | 15:55 | ||||||||
16:00 | 16:00 | ||||||||
16:05 | 16:05 | ||||||||
16:10 | 16:10 | ||||||||
16:15 | Technology Spotlights |
16:15 | |||||||
16:20 | 16:20 | ||||||||
16:25 | 16:25 | ||||||||
16:30 | New Approaches in Infection Biology Inhibition of bacterial virulence as an alternative to antibiotic treatment: Pseudomonas aeruginosa elastase as a target for antivirulence therapy 16:30 (30 mins) Martin Everett, Antabio |
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd How to build a mobile lab for genomic surveillance of viral outbreaks 16:30 (30 mins) Joshua Quick, Institute of Microbiology and infection, University of Birmingham |
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA X-reactivation as an approach to treating Rett Syndrome 16:30 (30 mins) Jeannie Lee, Harvard |
Alzheimer’s Research UK Novel Therapeutic Targets for Treatment of Neurodegeneration 16:30 (30 mins) Paul Brennan, Oxford DDI |
16:30 | ||||
16:35 | 16:35 | ||||||||
16:40 | 16:40 | ||||||||
16:45 | 16:45 | ||||||||
16:50 | 16:50 | ||||||||
16:55 | 16:55 | ||||||||
17:00 | Networking & Posters | 17:00 | |||||||
17:05 | 17:05 | ||||||||
17:10 | 17:10 | ||||||||
17:15 | 17:15 | ||||||||
17:20 | 17:20 | ||||||||
17:25 | 17:25 | ||||||||
17:30 | 17:30 | ||||||||
17:35 | 17:35 | ||||||||
17:40 | 17:40 | ||||||||
17:45 | 17:45 | ||||||||
17:50 | 17:50 | ||||||||
17:55 | 17:55 | ||||||||
18:00 | 18:00 | ||||||||
18:05 | 18:05 | ||||||||
18:10 | 18:10 | ||||||||
18:15 | 18:15 | ||||||||
18:20 | 18:20 | ||||||||
18:25 | 18:25 | ||||||||
18:30 | 18:30 | ||||||||
18:35 | 18:35 | ||||||||
18:40 | 18:40 | ||||||||
18:45 | 18:45 | ||||||||
18:50 | 18:50 | ||||||||
18:55 | 18:55 | ||||||||
19:00 | 19:00 |